BioCentury | Feb 8, 2019
Company News

Management tracks: Takeda’s Plump becomes president of R&D

...neuron-specific gene therapy targeting caveolin 1 caveolae protein 22kDa (CAV1) overexpression to treat neurodegenerative diseases. BC Staff CaroGen Corp. Graybug...
Items per page:
1 - 1 of 1
BioCentury | Feb 8, 2019
Company News

Management tracks: Takeda’s Plump becomes president of R&D

...neuron-specific gene therapy targeting caveolin 1 caveolae protein 22kDa (CAV1) overexpression to treat neurodegenerative diseases. BC Staff CaroGen Corp. Graybug...
Items per page:
1 - 1 of 1